[Diagnosis and treatment of sacral and retrorectal tumors. I].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Levin.
Explore the source record for details and available documents.
Forty-three sacral and retrorectal tumors encountered at the Cleveland Clinic were reviewed, with emphasis on incidence, diagnosis, and management. Benign tumors could be differentiated from malignant lesions on the basis of history, physical examination, and radiologic studies. CT scan and Magnetic Resonance Imaging are the most useful tests for staging. Small benign tumors may be removed through a posterior approach. All malignant lesions, and benign lesions greater than 3-4 cm in size should be removed through a combined anterior and posterior approach. All tumors should be completely removed wherever possible, since both benign and malignant tumors will recur when excision is incomplete. Radiotherapy and chemotherapy may provide some palliation for malignant tumors, but these modalities are not curative in our experience.
Left ventricular myocardial mass can be measured by 201Tl SPECT, but the effects of changes in heart rate and contractility have not been determined. We constructed a dynamic computer model simulating the contracting left ventricle. Thirty two summed static views at each of 3 heart rates and 3 ejection fractions were manufactured to simulate a 180 degrees acquisition. Each image set underwent tomographic reconstruction. Left ventricular mass was measured at a fixed percent threshold in each slice. The results show that left ventricular mass varied little with heart rate (4%) and only slightly more (8%) with ejection fraction. Thus, in the normal clinical setting, left ventricular mass measurements by SPECT are minimally affected by the dynamic state of the heart.
A premature infant with unilateral aniridia and congenital ectropion uveae, contralateral Rieger anomaly, bilateral congenital glaucoma, and hydrocephalus was found to have ring chromosome 6. The findings are consistent with multiple manifestations of a neural crest-derived maldevelopment of the anterior segment and central nervous system. Comparison with the 14 previously reported cases of ring chromosome 6 illustrates the phenotypic variability of this syndrome.
During routine coronary cinearteriography, a large, right atrial myxoma was detected in a patient with angina pectoris. It was clinically unsuspected and was found at surgery to extend partially into the left atrium.
Myocardial perfusion imaging is generally performed as a static acquisition without regard for dynamic changes in the cardiac cycle. The effect of heart rate and ejection fraction on the appearance of left ventricular chamber size and wall thickness as perceived in 201Tl scintigrams has not, to our knowledge, been previously studied. A dynamic computer model of the left ventricle was constructed, capable of varying the heart rate and ejection fraction. Parallel slices through the model were convolved with experimentally derived 201Tl point spread functions at corresponding depths to incorporate the effects of scatter and attenuation. Both gated and static left anterior oblique images were created at three clinically encountered heart rates and ejection fractions, with constant end-diastolic volume and left ventricular mass. Results of the study indicate that perceived and quantified wall thickness increases and chamber size decreases appreciably with increasing ejection fraction and (slightly) with increasing heart rate. Thus, evaluation of wall thickness and chamber size in planar images should take into account variations in heart rate and contractility. This is especially pertinent to estimates of left ventricular hypertrophy and chamber size, attempted from nongated myocardial perfusion images.
Differences in vertical orientation of the left ventricle within the chest cavity cannot be corrected by gamma camera positioning. The effect of variations in vertical angulation on the appearance of the diagnostically important left anterior oblique (LAO) view has not been previously evaluated. In the current study, a computer simulation of a normal left ventricle was created and "imaged," varying only the degree of vertical rotation. The effect of six vertical positions on the LAO image was assessed visually and with horizontal and circumferential profile analysis. Results indicate a homogenous distribution of counts in the horizontal views. With increasing verticality, there are fewer counts in the valve plane, while the inferoapex initially increases in count density, and then progressively decreases. Quantification revealed count variations of up to 37% in the valve plane and 45% in the inferoapex due entirely to differences in vertical orientation of the left ventricular simulation. A survey of 167 patients who underwent routine stress thallium imaging showed a vertical angulation that varied from 7 degrees to 64 degrees (mean = 37 degrees) as determined from the anterior view. Clinical images were similar in appearance to computer generated images after correction for anterior view foreshortening. The present study suggests that the accuracy of current quantitative thallium methods to detect coronary artery disease might be enhanced by the use of a revised set of normal standards corrected for vertical orientation of the left ventricle.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Elevation of intrathoracic pressure during cardiopulmonary resuscitation generates carotid pressure and flow, but also increases intracranial pressure. This increase in intracranial pressure may limit cerebral blood flow. Therefore, we performed studies designed to quantify the extent of this transmission and to identify the mechanism of transmission of intrathoracic pressure to the intracranial space during cardiopulmonary resuscitation in dogs. Intracranial pressure increased during the chest compression phase of all modes of cardiopulmonary resuscitation tested. During simultaneous compression-ventilation cardiopulmonary resuscitation, change in intracranial pressure (mm Hg) = 0.33 change in intrathoracic pressure (mm Hg) + 2.02 (r = 0.86) and was not significantly different from the relationship observed during conventional cardiopulmonary resuscitation. The magnitude of transmission of intrathoracic pressure to the intracranial space was increased by binding the abdomen and by raising the baseline intracranial pressure. No single route accounted for transmission of intrathoracic pressure to the intracranial space during cardiopulmonary resuscitation. Intracranial pressure fluctuations were unrelated to either carotid arterial or jugular venous pressure, and were found instead to be the result of pressure transmission by blood in non-valved veins and by cerebrospinal fluid. This was determined by three maneuvers. First, obstruction of cerebrospinal fluid flow by ligation of the cervical spinal cord reduced intracranial pressure (P less than 0.001) and made the change in intracranial pressure equivalent to pressure changes at the confluence of the intracranial venous sinuses, without affecting pressure changes at the confluence of the intracranial venous sinuses. Second, ligation of the cervical spinal cord and one of the two longitudinal vertebral veins adjacent to the cervical cord reduced the pressure changes in the intracranial space and at the confluence of the intracranial venous sinuses to about 60% of the levels observed when the cervical cord alone was ligated. Thus, the non-valved longitudinal vertebral veins appear to be the vascular channels of critical importance to pressure transmission. Finally, pressure changes in the thoracic cerebrospinal fluid were increased (P less than 0.05) by cord ligation, even after exsanguination minimized pressure transmission via blood-filled channels, indicating direct transmission of intrathoracic pressure through intervertebral foramina to the cerebrospinal fluid.(ABSTRACT TRUNCATED AT 400 WORDS)
Explore the source record for details and available documents.
Over a 24-month period, the Southwest Oncology Group (SWOG) conducted a randomized prospective chemotherapeutic trial in 158 patients with advanced prostatic cancer. Patients were initially randomized to receive either a combination of Adriamycin and cyclophosphamide (AC) or a single agent, hydroxyurea (H), and then crossed over to the other treatment on failure. Of the 137 evaluable patients, 43 (31%) had classically measurable metastatic disease in the lymph nodes, skin, chest, or liver. Focusing their efforts on this subset of patients with measurable disease, the authors of this report found the combination AC to have a superior response rate to the single agent, hydroxyurea. Objective response to AC was seen in 6 of 19 (32%) and in only one of 24 (4%) patients randomized to hydroxyurea (P = 0.06, Fisher's exact test). However, in the larger group of 137 evaluable patients, a survival advantage was not seen for those individuals treated with AC. Failure to demonstrate a survival advantage for an objectively superior drug combination would suggest the need for more active phase II agents in this disease.
Lymphangiomyomatosis is an interesting disease with distinctive clinical and histopathologic findings. We report herein two additional cases of lymphangiomyomatosis, including one with clinical improvement after therapy with progesterone. This case is of particular significance in view of the patient's negative sex steroid receptor analysis. These findings open new avenues for future considerations in the therapy of this unusual but interesting disease.
Explore the source record for details and available documents.
Patients with advanced transitional cell bladder carcinoma were randomized to receive either adriamycin alone, or adriamycin plus DDP. Overall response (CR + PR) was 8/41 (19%) for adriamycin alone versus 16/37 (43%) for the combination (p = 0.02). Median response duration was 14 weeks for adriamycin versus 25 weeks for the combination (p = 0.17). Median survival was 28 weeks on adriamycin versus 31 weeks on the combination (p = 0.82). Median survival of responders was 43 weeks, and for patients with stable disease it was 29 weeks. This was significantly better than for those with increasing disease at 15 weeks (p = 0.02). Increased frequency of leukopenia and gastrointestinal toxicity were seen with the combination. Cardiotoxicity and nephrotoxicity were not prohibitive.
We studied the function of right internal jugular vein valves during cardiac catheterization in 32 patients and external jugular vein valves in vitro from 13 dogs. Patients with normal central venous pressure had competent valves during cough-induced transvalvular pressure gradients of 52.4 +/- 8.6 mm Hg. Ten of 15 patients with elevated central venous pressure had either incompetent or absent internal jugular valves, the latter occurring only in patients with long-standing, severe tricuspid regurgitation. During coughing, competent valves were also demonstrated in the left internal jugular and in the right and left subclavian veins. The excised canine valves were competent at a static transvalvular pressure of 81.8 +/- 3.7 mm Hg. Five of six excised valves remained competent during pulsatile transvalvular pressure of 64.8 +/- 1.9 mm Hg. Thus, thoracic inlet venous valves are usually competent during sudden increases in intrathoracic pressure. These valves may play an important role in establishing the extrathoracic arteriovenous pressure gradient necessary for forward blood flow during cardiopulmonary resuscitation and other states with high intrathoracic pressure.
We reviewed 47 renal transplant recipients who had undergone angiography and transplant biopsy to evaluate impaired allograft function. Angiographic criteria for rejection were seen in all allografts with hyperacute rejection, accelerated rejection and chronic rejection, and in 13 of 17 allografts with acute cellular rejection. Angiography was normal in allografts with vasomotor nephropathy or transplant glomerulopathy. Angiography is an accurate method for the diagnosis of most causes of post-transplant dysfunction.
A controlled canine experimental study has been performed to test the application of a biodegradeable graft to vesical augmentation. The graft, after providing initial bladder enlargement, is progressively reabsorbed while serving as a foundation for the regeneration and healing of the layers of the bladder remnant. Follow-up studies at 1 year revealed no urinary infection, calculi, extravasation of urine, or rejection of the material. Normal bladder capacities were maintained throughout the study and the reconstructed bladders functioned normally. The biodegradable graft was equally successful when applied either to a histologically normal bladder remnant, or to a pathological bladder of intramural fibrosis. These results suggest that this material may be well suited to clinical bladder substitution in humans.